Effects of vitamin K2 on the development of osteopenia in rats as the models of osteoporosis

Yonsei Medical Journal

Volumn 47, Issue 2, 2006, Pages 157-166

  Iwamoto, Jun ^a   Takeda, Tsuyoshi ^a   Sato, Yoshihiro ^b  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Mitate Hospital   (Japan)

Author keywords

Bone formation; Bone resorption; Osteopenia; Rat; Vitamin K2

Indexed keywords

ALFACALCIDOL; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; FARNOQUINONE; GLUCOCORTICOID; INCADRONIC ACID; MAGNESIUM; PARATHYROID HORMONE; PREDNISOLONE; RALOXIFENE; RISEDRONIC ACID;

BONE GROWTH; BONE MASS; BONE METABOLISM; BONE STRENGTH; BONE TURNOVER; CALCIUM ABSORPTION; CALCIUM DEFICIENCY; CANCELLOUS BONE; CORTICAL BONE; DISEASE MODEL; DRUG POTENTIATION; FEMUR NECK; IMMOBILIZATION; INHIBITION KINETICS; JAPAN; LONG BONE; MAGNESIUM DEFICIENCY; NEURECTOMY; NONHUMAN; ORCHIECTOMY; OSSIFICATION; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; OVARIECTOMY; RAT; REVIEW; SCIATIC NERVE; TRABECULAR BONE; ANIMAL; ARTICLE; BONE; CHEMISTRY; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFECT; FEMALE; HOMEOSTASIS; MALE; METABOLIC BONE DISEASE; METABOLISM; PATHOLOGY; TIBIA;

ANIMALS; BONE AND BONES; BONE DISEASES, METABOLIC; BONE RESORPTION; CALCIUM; DIPHOSPHONATES; DISEASE MODELS, ANIMAL; FEMALE; HOMEOSTASIS; MAGNESIUM; MAGNESIUM DEFICIENCY; MALE; OSTEOPOROSIS; RATS; TIBIA; TOMOGRAPHY, X-RAY COMPUTED; VITAMIN K 2;

EID: 33646182428     PISSN: 05135796     EISSN: 05135796     Source Type: Journal    
DOI: 10.3349/ymj.2006.47.2.157     Document Type: Review

References (61)

1. 2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR. J Biol Chem 2003;278:43919-27.
2. Hauschka PV, Lian JB, Cole DE, Gundberg CM. Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev 1989;69:990-1047.
3. 2 enhances osteocalcin accumulation in the extracellular matrix of human osteoblasts in vitro. J Bone Miner Res 1997;12:431-8.
4. Shearer MJ. Vitamin K. Lancet 1995;345:229-34.
5. Vermeer C, Jie KS, Knapen MH. Role of vitamin K in bone metabolism. Annu Rev Nutr 1995;15:1-22.
6. 2 inhibits adipogenesis, osteoclastogenesis, and ODF/RANK ligand expression in murine bone marrow cell cultures. Bone 2000;27:769-76.
7. 2 inhibits osteoclastic bone resorption by inducing osteoclast apoptosis. Biochem Biophys Res Commun 1996;220:515-9.
8. Notoya K, Yoshida K, Shirakawa Y, Taketomi S, Tsuda M. Similarities and differences between the effects of ipriflavone and vitamin K on bone resorption and formation in vitro. Bone 1995;16 Suppl:349S-53S.
9. 2 (menatetrenone) on bone resorption may be related to its side chain. Bone 1995;16:179-84.
10. 2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J Bone Miner Res 2000;15:515-21.
11. Ishida Y, Kawai S. Comparative efficacy of hormone replacement therapy, etidronate, calcitonin, alfacalcidol, and vitamin K in postmenopausal women with osteoporosis: The Yamaguchi Osteoporosis Study. Am J Med 2004;117:549-55.
12. 2 and bisphosphonate in postmenopausal women with osteoporosis. Yonsei Med J 2003; 44:751-6.
13. 2 inhibits glucocorticoid-induced bone loss partly by preventing the reduction of osteoprotegerin (OPG). J Bone Miner Metab 2005;23: 41-7.
14. Tanaka I, Oshima K. Prevention of vertebral fractures with therapeutic agents in corticosteroid-induced osteoporosis. Osteoporosis Japan 2002;10:244-7 (in Japanese).
15. Tanaka I, Oshima K. Effects of menatetrenone, a vitamin K analog, on prevention of vertebral fracture in corticosteroid-induced osteoporosis. J Bone Miner Res 2001;16 Suppl 1:S531.
16. 2 (menatetrenone) treatment in children treated with glucocorticoid and alfacalcidol. Endocr J 2001;48:11-8.
17. Yonemura K, Kimura M, Miyaji T, Hishida A. Short-term effect of vitamin K administration on prednisolone-induced loss of bone mineral density in patients with chronic glomerulonephritis. Calcif Tissue Int 2000; 66:123-8.
18. 2 inhibits glucocorticoid-induced loss of bone mineral density in patients with chronic glomerulonephritis. Calcif Tissue Int 2000;6: 123-8.
19. Sato Y, Honda Y, Kuno H, Oizumi K. Menatetrenone ameliorates osteopenia in disuse-affected limbs of vitamin D- and K-deficient stroke patients. Bone 1998; 23:291-6.
20. Sato Y, Honda Y, Kaji M, Asoh T, Hosokawa K, Kondo I, et al. Amelioration of osteoporosis by menatetrenone in elderly female Parkinson's disease patients with vitamin D deficiency. Bone 2002;31:114-8.
21. 2 with calcium supplements prevent nonvertebral fracture in elderly women with Alzheimer's disease. Bone 2005;36:61-8.
22. 2 (menatetrenone) for bone loss in patients with cirrhosis of the liver. Am J Gastroenterol 2002;97:978-81.
23. Szulc P, Chapuy MC, Meunier PJ, Delmas PD. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 1993; 91: 1769-74.
24. Szulc P, Chapuy MC, Meunier PJ, Delmas PD. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three year follow-up study. Bone 1996; 18:487-8.
25. Vergnaud P, Garnero P, Meunier PJ, Breart G, Kamihagi K, Delmas PD. Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study. J Clin Endocrinol Metab 1997;82:719-24.
26. Luukinen H, Kakonen SM, Pettersson K, Koski K, Laippala P, Lovgren T, et al. Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin. J Bone Miner Res 2000;15: 2473-8.
27. Feskanich D, Weber P, Willett WC, Rockett H, Booth SL, Colditz GA. Vitamin K intake and hip fractures in women: a prospective study. Am J Clin Nutr 1999;69: 74-9.
28. Sato Y, Honda Y, Hayashida N, Iwamoto J, Kanoko T, Satoh K. Vitamin K deficiency and osteopenia in elderly women with Alzheimer's disease. Arch Phys Med Rehabil 2005;86:576-81.
29. 2 (menatetrenone) on bone resorption in ovariectomized rats: a histomorphometric and dual energy X-ray absorptiometric study. Jpn J Pharmacol 1999;80:67-74.
30. Asawa Y, Amizuka N, Hara K, Kobayashi M, Aita M, Li M, et al. Histochemical evaluation for the biological effect of menatetrenone on metaphyseal trabeculae of ovariectomized rats. Bone 2004;35:870-80.
31. 2 on three-dimensional trabecular microarchitecture in ovariectomized rats. J Bone Miner Res 2000; 15:1810-7.
32. 2 on lumbar vertebral bone: histomorphometric analyses in experimental osteoporotic rats. J Orthop Sci 2001;6:535-9.
33. Shiraishi A, Higashi S, Masaki T, Saito M, Ito M, Ikeda S, et al. A comparison of alfacalcidol and menatetrenone for the treatment of bone loss on an ovariectomized rat model of osteoporosis. Calcif Tissue Int 2002;71: 69-79.
34. Binkley N, Krueger D, Engelke J, Crenshaw T, Suttie J. Vitamin K supplementation does not affect ovariectomy-induced bone loss in rats. Bone 2002;30:897-900.
35. 2. J Bone Miner Metab 2004;22:404-14.
36. Matsunaga S, Ito H, Sakou T. The effect of vitamin K and D supplementation on ovariectomy-induced bone loss. Calcif Tissue Int 1999;65:285-9.
37. 3 on bone loss in ovariectomized rats. Foila Pharmacol Jpn 2001;118:231-40 (in Japanese).
38. Ito M. Bone mass, microstructure, and quality with bone strength-The effects of antiresorptive agents. J Jpn Soc Bone Morphom 2002;12:51-4 (in Japanese).
39. 2 combine to improve the femoral neck strength of ovariectomized rats. Calcif Tissue Int 2005 (Epub a head of print).
40. Bertelloni S, Baroncelli GI, Battini R, Perri G, Saggese G. Short-term effect of testosterone treatment on reduced bone density in boys with constitutional delay of puberty. J Bone Miner Res 1995;10:1488-95.
41. Guo CY, Jones TH, Eastell R. Treatment of isolated hypogonadotropic hypogonadism effect on bone mineral density and bone turnover. J Clin Endocrinol Metab 1997;82:658-65.
42. Behre HM, Kliesch S, Leifke E, Link TM, Nieschlag E. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. J Clin Endocrinol Metab 1997;82:2386-90.
43. Erben RG, Eberle J, Stahr K, Goldberg M. Androgen deficiency induces high turnover osteopenia in aged male rats: a sequential histomorphometric study. J Bone Miner Res 2000;15:1085-98.
44. Prakasam G, Yeh JK, Chen MM, Castro-Magana M, Liang CT, Aloia JF. Effects of growth hormone and testosterone on cortical bone formation and bone density in aged orchidectomized rats. Bone 1999;24: 491-7.
45. 2 on cortical and cancellous bones in orchidectomized and/or sciatic neurectomized rats. J Bone Miner Res 2003; 18:776-83.
46. 2 (menatetrenone) inhibits bone loss induced by prednisolone partly through enhancement of bone formation in rats. Bone 2002;31:575-81.
47. Hara K, Akiyama Y, Ohkawa I, Tajima T. Effects of menatetrenone on prednisolone-induced bone loss in rats. Bone 1993;14:813-8.
48. Iwasaki Y, Yamato H, Murayama H, Takahashi T, Ezawa I, Kurokawa K, et al. Menatetrenone prevents osteoblast dysfunction in unilateral sciatic neurectomized rats. Jpn J Pharmacol 2002;90:88-93.
49. Iwasaki-Ishizuka Y, Yamato H, Murayama H, Abe M, Takahashi K, Kurokawa K, et al. Menatetrenone ameliorates reduction in bone mineral density and bone strength in sciatic neurectomized rats. J Nutr Sci Vitaminol 2003;49:256-61.
50. Iwasaki-Ishizuka Y, Yamato H, Murayama H, Ezawa I, Kurokawa K, Fukagawa M. Menatetrenone rescues bone loss by improving osteoblast dysfunction in rats immobilized by sciatic neurectomy. Life Sci 2005;76: 1721-34.
51. Kodama Y, Nakayama K, Fuse H, Fukumoto S, Nawahara H, Takahashi H, et al. Inhibition of bone resorption by pamidronate cannot restore normal gain in cortical bone mass and strength in tail-suspended rapidly growing rats. J Bone Miner Res 1997;12:1058-67.
52. Moriyama I, Iwamoto J, Takeda T, Toyama Y. Comparative effects of intermittent administration of human parathyroid hormone (1-34) on cancellous and cortical bone loss in tail-suspended and sciatic neurectomized young rats. J Orthop Sci 2002;7:379-85.
53. 2 in mature rats with long-term tail suspension. J Bone Miner Metab 2002;20: 216-22.
54. Morey ER, Baylink DJ. Inhibition of bone formation during space flight. Science 1978;201:1138-41.
55. 2 further increases bone volume and ameliorates extremely low turnover bone induced by bisphosphonate therapy in tail-suspension rats. J Bone Miner Metab 2003;21:154-60.
56. Kato S, Mano T, Kobayashi T, Yamazaki N, Himeno Y, Yamamoto K, et al. A calcium-deficient diet caused decreased bone mineral density and secondary elevation of estrogen in aged male rats-effect of menatetrenone and elcatonin. Metabolism 2002;51:1230-4.
57. Iwamoto J, Yeh JK, Takeda T, Ichimura, S, Sato Y. Comparative effect of vitamin K and vitamin D supplementation on prevention of osteopenia in calcium-deficient young rats. Bone 2003;33:557-66.
58. Robert D, Jorgetti V, Lacour B, Leclerq M, Cournot-Witmer G, Ulmann A, et al. Hypercalciuria during experimental vitamin K deficiency in the rat. Calcif Tissue Int 1985;37:143-7.
59. 2) on bone mineral density and bone strength in Ca/Mg deficient rats. Nippon Yakurigaku Zasshi 2002;120:195-204 (in Japanese).
60. 2 (menatetrenone) on calcium balance in ovariectomized rats. Jpn J Pharmacol 2002,88:55-61.
61. 2 (menatetrenone) and alendronate on bone mineral density and bone strength in rats fed a low-magnesium diet. Bone 2004;35:1136-43.